Skip to content

A superiority open-label parallel group randomized controlled trial for investigating the efficacy of a biomedical video lecture compared to a video lecture with recommended messages for reducing feasible knowledge toward people with mental health problems

A superiority open-label parallel group randomized controlled trial for investigating the efficacy of a biomedical video lecture compared to a video lecture with recommended messages for reducing feasible knowledge toward people with mental health problems - A randomized controlled trial for investigating the efficacy of a biomedical video lecture for reducing feasible knowledge toward people with mental health problems

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000027727
Enrollment
170
Registered
2017-06-15
Start date
2017-06-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General population

Interventions

A 10-min biomedical video lecture (BMD) A 10-min video lecture with recommended messages (RMD)

Sponsors

The University of Tokyo
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Those who were recruited by website recruitment boards.

Exclusion criteria

Exclusion criteria: Those who are unable to read and write in Japanese equivalent to the graduation of junior high school in Japan.

Design outcomes

Primary

MeasureTime frame
Change in feasible knowledge of stigma toward people with mental health problems measured using the Mental Illness and Disorder Understanding Scale(MIDUS) from the baseline to the post intervention

Secondary

MeasureTime frame
Change in behavioural intention measured using the Reported and Intended Behaviour Scale (RIBS-J) and help seeking intention toward themselves and people with mental health problems measured using help seeking intention questionnaires (Rusch et al. Psychiatr Serv 2011) from the baseline to the post intervention, and the 1-month and 12-month follow-ups. Change in the MIDUS score from the baseline to the 1-month and 12-month follow-ups was also compared. We also intend to define 25% or more decrease of RIBS-J score (1SD change from Koike et al. EPS 2016) from the baseline to each follow-up as the increase of stigma, and compare the number of those who have increase of stigma between the groups.

Countries

Japan

Contacts

Public ContactShinsuke Koike

The University of Tokyo Graduate School of Arts and Sciences

skoike-tky@umin.ac.jp0354544327

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026